Stamos Capital Partners, L.P.

Position in AMGN — Amgen Inc

CIK 1705399 Menlo Park, CA

Position in AMGN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$766,970

+$87,900 QoQ

Shares Held

2,118

+9.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#1,882

of 3,140 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stamos Capital Partners, L.P. holds $64,248,987 across 8 Drug Manufacturers - General names. AMGN ranks #8 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	179,799	$23,104,171
2	JNJ	Johnson & Johnson	43,175	$10,965,154
3	NVO	Novo Nordisk A S	184,608	$8,850,107
4	PFE	Pfizer Inc	297,285	$7,158,622
5	LLY	ELI LILLY & Co	5,449	$6,535,694
6	GSK	GSK plc	114,724	$6,013,832
7	GILD	Gilead Sciences, Inc.	6,763	$854,437
8	AMGN	Amgen Inc This page	2,118	$766,970

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$766,970	2,118	+9.7%	Shares	Sole	2026-08-13
2026-03-31	$679,070	1,930	-15.5%	Shares	Sole	2026-05-14
2025-12-31	$747,576	2,284	-12.4%	Shares	Sole	2026-02-12
2025-09-30	$735,977	2,608	-37.0%	Shares	Sole	2025-11-13
2025-06-30	$1,155,929	4,140	+12.2%	Shares	Sole	2025-08-14
2025-03-31	$1,149,931	3,691	-45.2%	Shares	Sole	2025-05-14
2024-12-31	$1,754,107	6,730	+69.5%	Shares	Sole	2025-02-13
2024-09-30	$1,279,173	3,970	-1.5%	Shares	Sole	2024-11-13
2024-06-30	$1,259,173	4,030	+4.4%	Shares	Sole	2024-08-13
2024-03-31	$1,097,475	3,860	-11.1%	Shares	Sole	2024-05-14
2023-12-31	$1,250,006	4,340	-68.4%	Shares	Sole	2024-02-13
2023-09-30	$3,695,450	13,750	-9.3%	Shares	Sole	2023-11-13
2023-06-30	$3,365,823	15,160	+18.5%	Shares	Sole	2023-08-11
2023-03-31	$3,091,982	12,790	+24.9%	Shares	Sole	2023-05-12
2022-12-31	$2,689,433	10,240	-22.9%	Shares	Sole	2023-02-13
2022-09-30	$2,995,566	13,290	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.